Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6c9201213e4a966d85cbcd61f66e805 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-12334 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18434 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88 |
filingDate |
2001-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f968c01d74e7f719380262dd16ec6645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a6c866e41bc70299e530a6e1551a29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b69fc049848228aa069bedd2e7875ee2 |
publicationDate |
2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002034551-A1 |
titleOfInvention |
Method of making microencapsulated DNA for vaccination and gene therapy |
abstract |
A method of making a microparticle that contains DNA coding for a polypeptide is described in which a solvent extraction method is used and solvent extraction takes place at elevated temperature. Oral administration of the microparticle leads to its expression. DNA coding for an immunogen is for stimulating antibody formation in a recipient and DNA coding for a non-immunogenic polypeptide is for gene therapy applications. DNA is incorporated into the microparticle without destruction of its function. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883200-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009171077-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004037874-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006039355-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03097805-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8496961-B2 |
priorityDate |
1995-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |